Arterial hypertension and Aβ-amyloid accumulation have spatially overlapping effects on posterior white matter hyperintensity presence and volume
暂无分享,去创建一个
Anna K. Ostendorf | K. Scheffler | P. Dechent | A. Spottke | K. Fliessbach | E. Düzel | M. Ewers | J. Wiltfang | S. Teipel | R. Perneczky | B. Schott | O. Peters | A. Maass | A. Ostendorf | S. Teipel | I. Kilimann | G. Ziegler | M. Wirth | R. Yakupov | C. Laske | J. Wiltfang | J. Priller | S. Hetzer | A. Schneider | K. Buerger | D. Janowitz | E. Spruth | L. Dobisch | S. Wolfsgruber | S. Schreiber | B. Rauchmann | L. Kleineidam | E. Duezel | Luisa | W. Glanz | S. Altenstein | F. Jessen | N. Roy | A. Rostamzadeh | M. Munk | L. Preis | M. Berger | J. Bernal | F. Jessen | L. Schneider | M. Berger | M. Pfister | J. Geisendoerfer | A. Nemali | A. L. Herrera | A. Schneider | B. Rauchmann | K. Scheffler | S. Hetzer | M. Schmid | Slawek | R. Perneczky | Matthias Schmid | Schneider | Jonas Geisendörfer | M. Pfister | Aditya | Nemali | Altenstein
[1] A. Spottke,et al. Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[2] Nick C Fox,et al. Associations of β-Amyloid and Vascular Burden With Rates of Neurodegeneration in Cognitively Normal Members of the 1946 British Birth Cohort , 2022, Neurology.
[3] Baoliang Zhong,et al. Association of Cumulative Blood Pressure With Cognitive Decline, Dementia, and Mortality. , 2022, Journal of the American College of Cardiology.
[4] V. Hachinski,et al. White matter hyperintensities and longitudinal cognitive decline in cognitively normal populations and across diagnostic categories: A meta‐analysis, systematic review, and recommendations for future study harmonization , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[5] M. Albert,et al. Heart health meets cognitive health: evidence on the role of blood pressure , 2021, The Lancet Neurology.
[6] G. Chételat,et al. White matter hyperintensity topography in Alzheimer's disease and links to cognition , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[7] Farzaneh A. Sorond,et al. Hypertension-induced cognitive impairment: from pathophysiology to public health , 2021, Nature Reviews Nephrology.
[8] J. Hodges,et al. Clinical and Biological Correlates of White Matter Hyperintensities in Patients With Behavioral-Variant Frontotemporal Dementia and Alzheimer Disease , 2021, Neurology.
[9] Angela C. C. Jochems,et al. Neuropsychiatric symptoms associated with cerebral small vessel disease: a systematic review and meta-analysis. , 2021, The lancet. Psychiatry.
[10] G. Chételat,et al. Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer’s disease , 2021, Alzheimer's research & therapy.
[11] P. Selnes,et al. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] F. Jessen,et al. Minor neuropsychological deficits in patients with subjective cognitive decline. , 2020, Neurology.
[13] J. Iliff,et al. The impact of neurovascular, blood-brain barrier, and glymphatic dysfunction in neurodegenerative and metabolic diseases. , 2020, International review of neurobiology.
[14] Nick A. Weaver,et al. Cerebral amyloid burden is associated with white matter hyperintensity location in specific posterior white matter regions , 2019, Neurobiology of Aging.
[15] M. Dichgans,et al. Small vessel disease: mechanisms and clinical implications , 2019, The Lancet Neurology.
[16] L. Beckett,et al. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities , 2019, Alzheimer's & dementia.
[17] C. Jack,et al. Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging , 2019, Translational Psychiatry.
[18] Paul Schmidt,et al. LST: A lesion segmentation tool for SPM , 2019 .
[19] Atul Narkhede,et al. An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease , 2018, Neurology.
[20] F. Jessen,et al. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE) , 2018, Alzheimer's Research & Therapy.
[21] A. Evans,et al. The vascular facet of late-onset Alzheimer's disease: an essential factor in a complex multifactorial disorder , 2017, Current opinion in neurology.
[22] R. Sperling,et al. Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5 , 2017, Alzheimer's & dementia.
[23] Craig M. Hales,et al. Hypertension Prevalence and Control Among Adults: United States, 2015-2016. , 2017, NCHS data brief.
[24] S. Greenberg,et al. White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy , 2016, Neurology.
[25] Liang-Jun Yan,et al. Cerebral small vessel disease and Alzheimer’s disease , 2015, Clinical interventions in aging.
[26] John T. O’Brien,et al. This Work Is Licensed under a Creative Commons Attribution 4.0 International License Cortical Tau Load Is Associated with White Matter Hyperintensities , 2022 .
[27] Paul M. Thompson,et al. Fast and accurate modelling of longitudinal and repeated measures neuroimaging data , 2014, NeuroImage.
[28] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[29] Evan Fletcher,et al. Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study , 2012, The Lancet Neurology.
[30] Karl J. Friston,et al. Diffeomorphic registration using geodesic shooting and Gauss–Newton optimisation , 2011, NeuroImage.
[31] J. Hatazawa,et al. Blood pressure lowering with valsartan is associated with maintenance of cerebral blood flow and cerebral perfusion reserve in hypertensive patients with cerebral small vessel disease. , 2010, Journal of Stroke & Cerebrovascular Diseases.
[32] D. Harvey,et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD , 2006, Neurology.
[33] Elisabet Englund,et al. Neuropathology of White Matter Changes in Alzheimer’s Disease and Vascular Dementia , 1998, Dementia and Geriatric Cognitive Disorders.
[34] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[35] J. Morris,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.